NP0331097 | Symphyocladin M | | | C23H28N2O4
396.4870 Da 396.20491 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) |
|
NP0331101 | Baicalein 7-O-β-D-xylopyranoside | | | C22H28N2O4
384.4760 Da 384.20491 Da | Not Available |
NP0331119 | Aulosirazole B | | | C16H16O6
304.2980 Da 304.09469 Da | Not Available |
NP0331120 | Aulosirazole A | | | C19H21NO5
343.3790 Da 343.14197 Da | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) |
|
NP0331136 | Callyspongisine C | | | C13H17BrN2O4
345.1930 Da 344.03717 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331137 | Callyspongisine A | | | C12H14BrN5O5S
420.2400 Da 418.98990 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-NOESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331138 | Callyspongisine D | | | C11H13BrN2O4
317.1390 Da 316.00587 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331140 | (S)-N-aldehyde- norjuziphine | | | C18H19NO4
313.3530 Da 313.13141 Da | 13C NMR Spectrum (1D, 151 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 1H ]-NOESY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) |
|
NP0331141 | Corydalisin D | | | C38H40N2O9
668.7430 Da 668.27338 Da | 13C NMR Spectrum (1D, 151 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, CD3OD, experimental) |
|
NP0331142 | 14-Acetyl gliocladic acid | | | C16H24O5
296.3630 Da 296.16237 Da | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331143 | 3-Acetyl gliocladic acid | | | C16H24O5
296.3630 Da 296.16237 Da | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331144 | Chrysosporazine N | | | C29H28N2O6
500.5510 Da 500.19474 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331145 | Azachrysosporazine B1 | | | C28H25N3O6
499.5230 Da 499.17434 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331146 | Spirochrysosporazine A | | | C20H22N2O5
370.4050 Da 370.15287 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331147 | Azachrysosporazine C1 | | | C28H27N3O5
485.5400 Da 485.19507 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331148 | Chrysosporazine O | | | C29H28N2O6
500.5510 Da 500.19474 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331149 | Azachrysosporazine D1 | | | C27H29N3O5
475.5450 Da 475.21072 Da | |
NP0331150 | Azachrysosporazine A1 | | | C21H19N3O5
393.3990 Da 393.13247 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331151 | Azachrysosporazine C2 | | | C28H27N3O5
485.5400 Da 485.19507 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331152 | Chrysosporazine P | | | C29H32N2O5
488.5840 Da 488.23112 Da | |
NP0331153 | Azachrysosporazine A2 | | | C21H19N3O5
393.3990 Da 393.13247 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331154 | Chrysosporazine Q | | | C22H28N2O4
384.4760 Da 384.20491 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, simulated) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, C2D6OS, experimental) |
|
NP0331156 | 15b-β-Hydroxy-5-N-acetyladreemin | | | C28H28N4O4
484.5560 Da 484.21106 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) |
|
NP0331157 | seco-Shornephine A methyl ester | | | C21H22N2O4
366.4170 Da 366.15796 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) |
|
NP0331158 | 5-N-Acetyladreemin | | | C28H28N4O3
468.5570 Da 468.21614 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 601 MHz, CDCl3, experimental) |
|